<DOC>
	<DOCNO>NCT01756209</DOCNO>
	<brief_summary>Aim : The purpose study evaluate effect ibuprofen and/or acetaminophen acute treatment primary migraine child prophylactic treatment magnesium . Methods : The study approve Researchers Ethics Committee `` Pugliese-Ciaccio '' Hospital ( protocol number 720/2010 ; EUDRACT NUMBER 2012-005737-36 ) child range age 5 18 year least four attack/month primary migraine enrol . A Visual Analogical Scale use evaluate pain intensity moment admission study ( start study ) every month 18 month later ( end study ) .</brief_summary>
	<brief_title>Acetaminophen Ibuprofen With Without Magnesium Primary Migraine Childhood</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Children migraine without aura ( MoA ) sex age 5 18 year , least four attack /month , eligible study . MoA diagnose accord criterion pediatric age International Classification Headache Disorders ( IHS2 ) Exclusion criterion follow : mental retardation ( IQ &lt; 70 ) , genetic syndrome ( e.g. , Down syndrome , PraderWilli syndrome , fragile X syndrome ) , hypothyroidism , psychiatric disorder ( i.e . : schizophrenia , mood disorder , ADHD ) , neuromuscular disorder , epilepsy , obesity ( BMI &gt; 95 percentile ) , liver renal disease , gastrointestinal disorder peptic duodenal ulcer , dyspepsia , heartburn ; hypersensitivity medication study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>